A Practical Screening Combination for the Discrimination of Alzheimer's Type Memory Impairment Continuum: The 5-word Test and Magnetic Resonance Imaging-visual Rating Scale

Zerrin Yildirim,Ece Akalin-Akkas,Ulas Ay,Tugba Eyigürbüz,Nilüfer Kale

DOI: https://doi.org/10.4103/nsn.nsn_116_23

2024-03-30

Neurological Sciences and Neurophysiology

Abstract:Alzheimer's disease (AD) is a dual proteinopathy characterized by neurofibrillary tangles formed by intracellular accumulation of hyperphosphorylated tau fibrils and amyloid plaques consisting of extracellular amyloid-β (Aβ) deposits. [ 1 ] It has an incidence of 50%–70% among all dementia types, and its prevalence doubles every 5 years in the population over 65. Until the 2000s, the disease was considered clinically equivalent to dementia, and the diagnosis of the disease could only be made "probable or possible" when it was in the dementia stage, denoting multiple cognitive deficits with an amnestic core causing impairment in the activities of daily livings (ADL's). However, with the understanding that the disease has a preclinical stage extending up to 20 years before the first clinical symptoms start and then a predementia stage, the so-called mild cognitive impairment (MCI), denoting isolated amnestic or multiple-domain cognitive deficits with intact ADLs, the importance of early diagnosis of the disease has emerged. [ 2 ] With the development of disease-specific biomarkers, the use of biomarkers has been included in the disease's diagnostic criteria. [ 3-5 ] Thus, the progressive course of AD has now begun to be defined as a disease continuum. [ 6 ] In this continuum, the clinical stage that is AD dementia (ADD) appears quite late, which itself is divided into mild, moderate, and severe stages along its progression. In the preclinical AD stage, which lasts for decades before the clinical symptoms of ADD begin, the person is completely asymptomatic or may have subjective memory complaints. The latter complain that their memory is worse than in the past, but their performance remains within the normal range with the available neuropsychological memory tests. Since the complaint has no objective evidence, hence it is "subjective." This stage is called subjective cognitive impairment (SCI). [ 2 ]

neurosciences